Cargando…

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy

Patients receiving CD19 CAR T-cell therapy for relapsed/refractory lymphoma experience prolonged and profound B-cell aplasia and hypogammaglobulinemia, placing them at a higher risk for severe COVID-19. Independently, Oh et al and Atanackovic et al demonstrate that despite attenuated humoral respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atanackovic, Djordje, Luetkens, Tim, Omili, Destiny, Iraguha, Thierry, Lutfi, Forat, Hardy, Nancy M., Fan, Xiaoxuan, Avila, Stephanie V., Saharia, Kapil K., Husson, Jennifer S., Niederhaus, Silke V., Margiotta, Philip, Lee, Seung T., Law, Jennie Y., Mannuel, Heather D., Vander Mause, Erica, Bauman, Sherri, Lesho, Patricia, Hankey, Kim, Baddley, John, Kocoglu, Mehmet, Yared, Jean A., Rapoport, Aaron P., Dahiya, Saurabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Letters to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135504/ https://www.ncbi.nlm.nih.gov/pubmed/35537186 http://dx.doi.org/10.1182/blood.2022016175

Ejemplares similares

Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine
por: Saharia, Kapil K, et al.
Publicado: (2022)

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
por: Dahiya, Saurabh, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant
por: Atanackovic, Djordje, et al.
Publicado: (2021)

Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy
por: Dahiya, Saurabh, et al.
Publicado: (2021)

T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
por: Atanackovic, Djordje, et al.
Publicado: (2022)

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
por: Kline, Kathryn, et al.
Publicado: (2023)

Deep dissection of the antiviral immune profile of patients with COVID-19
por: Atanackovic, Djordje, et al.
Publicado: (2021)

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion
por: Olson, Michael L., et al.
Publicado: (2022)

Immunophenotypic Profiling of Immune Cells in Patients with and without Hematologic Malignancies Affected By Sars-COV-2 Infection
por: Sanchez-Petitto, Gabriela, et al.
Publicado: (2021)

Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
por: Luetkens, Tim, et al.
Publicado: (2020)

Role of immunotherapy in Ewing sarcoma
por: Morales, Erin, et al.
Publicado: (2020)

Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment
por: Serrano, Katherine, et al.
Publicado: (2010)

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Determinants of blood donation willingness in the European Union: a cross‐country perspective on perceived transfusion safety, concerns, and incentives
por: Huis in ‘t Veld, Elisabeth M.J., et al.
Publicado: (2019)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Barriers to blood donation on social media: An analysis of Facebook and Twitter posts
por: Ramondt, Steven, et al.
Publicado: (2020)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men
por: Castillo, Gisell, et al.
Publicado: (2022)

How to increase first‐time donors' returns? The postdonation letter's content can make a difference
por: Moussaoui, Lisa S., et al.
Publicado: (2022)

Sexual risk behavior questions: Understanding and mitigating donor discomfort
por: Haw, Jennie, et al.
Publicado: (2021)

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
por: Stramer, Susan L., et al.
Publicado: (2022)

Plasmavigilance—Adverse events among US Source plasma donors
por: Schreiber, George B., et al.
Publicado: (2021)

A robust autonomous method for blood demand forecasting
por: Turkulainen, Esa V., et al.
Publicado: (2022)

What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation
por: France, Christopher R., et al.
Publicado: (2022)

Predicting vasovagal reactions to a virtual blood donation using facial image analysis
por: Rudokaite, Judita, et al.
Publicado: (2022)

‘Stay at home and limit contact’: The impact of stay‐at‐home advice on the behavior of Australian donors aged 70 and over in the first year of the pandemic
por: Naing, Sanda, et al.
Publicado: (2022)

Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences
por: France, Christopher R., et al.
Publicado: (2022)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nkkgbh85la78r6kv8a50kg8dm4